Nicotine dihydrochloride

A major metabolite of nicotine that is often used as a biomarker to detect tobacco use binds nicotinic- and muscarinic-type acetylcholine receptors and demonstrates antipsychotic drug-like properties and neuroprotective properties.

A major metabolite of nicotine that is often used as a biomarker to detect tobacco use binds nicotinic- and muscarinic-type acetylcholine receptors and demonstrates antipsychotic drug-like properties and neuroprotective properties.

A major metabolite of nicotine that is often used as a biomarker to detect tobacco use binds nicotinic- and muscarinic-type acetylcholine receptors and demonstrates antipsychotic drug-like properties and neuroprotective properties.

A major metabolite of nicotine that is often used as a biomarker to detect tobacco use binds nicotinic- and muscarinic-type acetylcholine receptors and demonstrates antipsychotic drug-like properties and neuroprotective properties.

(1S)-Calcitriol (1α,25-Dihydroxy-3-epi-vitamin-D3) is a natural metabolite of 1α,25-dihydroxyvitamin D 3 (1α,25(OH) 2 D 3 ). (1S)-Calcitriol exhibits potent vitamin D receptor (VDR)-mediated actions such as inhibition of keratinocyte growth or

(1S)-Calcitriol (1α,25-Dihydroxy-3-epi-vitamin-D3) is a natural metabolite of 1α,25-dihydroxyvitamin D 3 (1α,25(OH) 2 D 3 ). (1S)-Calcitriol exhibits potent vitamin D receptor (VDR)-mediated actions such as inhibition of keratinocyte growth or

Application: A tobacco smoke-derived nitrosamine which is activated by multiple human cytochrome P 450s including the polymorphic human cytochrome P 4502D6.

Application: A tobacco smoke-derived nitrosamine which is activated by multiple human cytochrome P 450s including the polymorphic human cytochrome P 4502D6.

5-(4，4，5，5-Tetramethyl-1，3，2-dioxaborolan-2-yl)nicotinamide.

5-Ethynyl Nicotine is an intermediate of nicotinic acetylcholine receptor agonist SIB-1508Y.

ABT-107 is a selective α7 neuronal nicotinic receptor agonist. ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions.In VivoABT-107 exhibits good bioavailability in mouse (orally, 51.1%:

ABT-107 is a selective α7 neuronal nicotinic receptor agonist. ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions.In VivoABT-107 exhibits good bioavailability in mouse (orally, 51.1%: